Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats

Journal of Hypertension

Volumn 17, Issue 1, 1999, Pages 107-114

  Varo, Nerea ^a   Etayo, Juan C ^a   Zalba, Guillermo ^a   Beaumont, Javier ^a   Iraburu, María J ^a   Montiel, Cristina ^a   Gil, María J ^a   Monreal, Ignacio ^a   Díez, Javier ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Angiotensin; Collagen; Losartan; Myocardial fibrosis; Spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; COLLAGEN TYPE 1; LOSARTAN; MESSENGER RNA; PEPTIDE; PROCOLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HYPERTENSION; LONG TERM CARE; MALE; MORPHOMETRICS; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0033047723     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917010-00016     Document Type: Article

References (46)

1. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 1979;6;H461-H468.
2. Sen S, Bumpus FM. Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Am J Cardiol 1979;44:954-958.
3. Panizo A, Pardo J, Hernandez M, Galindo MF, Cenarruzabeitia E, Diez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995; 8:815-822.
4. Huysman JAN, Vliegen HW, Vanderlaarse A, Eulderink F. Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophied human hearts. Pathol Res Pract 1989; 184:577-581.
5. Pardo-Mindán FJ, Panizo A. Alterations in the extracellular matrix of the myocardium in essential hypertension. Eur Heart J 1993; 14 (suppl J): 12-14.
6. Olivetti G, Melissari M, Balbi T, Quaini F, Cigola E, Sonnenblick EH, et al. Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc Res 1994; 28:1199-1208.
7. Sun Y, Ramires FJA, Zhou G, Ganjam VK, Weber KT. Fibrous tissue and angiotensin II. J Mol Cell Cardiol 1997; 29:2001-2012.
8. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88:2849-2861.
9. Crabos M, Roth M, Hahn AWA, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts: coupling to signaling systems and gene expression. J Clin Invest 1994; 93:2372-2378.
10. Morton JJ, Beattie EC, MacPherson F. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J Vasc Res 1992; 29:264-269.
11. Oddie CJ, Dilley RJ. Bobik A. Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers. Clin Exp Pharmacol Physiol 1992; 19:392-395.
12. Gohlke P, Linz W, Schölkens BA, Wiemer G, Unger T. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1996; 28:397-402.
13. Ménard J, Campbell DJ, Azizi M, Gonzales MF. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 1997; 96:3072-3078.
14. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994; 74:727-739.
15. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 1995, 25:1252-1259.
16. Nicoletti A, Heudes D, Hinglais N, Appay MD, Philippe M, Sassy-Prigent C, et al. Left ventricular fibrosis in renovascular hypertensive rats: effect of losartan and spironolactone. Hypertension 1995; 26:101-111.
17. Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli JF. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharmacol 1993; 22:305-313.
18. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83:1771-1779.
19. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69:107-115.
20. van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5:2814-2823.
21. Díez J, Laviades C. Monitoring fibrillar collagen turnover in hypertensive heart disease. Cardiovasc Res 1997; 35:202-205.
22. Diez J, Panizo A, Gil MJ, Monreal I, Hernández M, Pardo Mindán J. Serum markers of collagen type I metabolism in spontaneously hypertensive rats. Circulation 1996; 93:1026-1032.
23. US National Institutes of Health. Guide for the care and use of laboratory animals, rev ed. Washington, DC: NIH Publication No. 85-23; 1985.
24. Lovenberg W. Techniques for the measurement of blood pressure. Hypertension 1987; 9 (suppl 1):15-16.
25. Richor C, Mulder P, Fornes P, Richard V, Camilleri JP, Giudicelli JF. Hemodynamic and morphological effects of quinapril during genetic hypertension development. J Cardiovasc Pharmacol 1991; 18: 631-642.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
27. Genovesc C, Rowe D, Kream B. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1.25-dihydroxyvitamin D. Biochemistry 1984; 23:6210-6216.
28. Dolber PC, Spach MS. Picrosirius red staining of cardiac muscle following phosphomolybdic acid treatment. Stain Technol 1987; 62:23-26.
29. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988; 62:757-765.
30. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats: lisinopril-mediated regression of myocardial fibrosis. Hypertension 1996; 28:269-275.
31. Diez J, Hernández M. Is the extracellular degradation of collagen type I fibers depressed in spontaneously hypertensive rats with myocardial fibrosis [abstract]? Circulation 1996; 24:2998.
32. 1-receptor antagonism on cardiovascular remodeling in aortic-banded rats. Am J Physiol 1997; 272:H2131-H2138.
33. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99:1926-1935.
34. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix components. Circ Res 1994; 75:23-32.
35. 1(I) collagen mRNA in myocardium from the spontaneously hypertensive rat during the transition from compensated hypertrophy to failure. J Mol Cell Cardiol 1997; 29:2335-2344.
36. Anversa P, Olivetti G, Lori A, Liu Y, Kajstura J. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens 1997; 6: 169-176.
37. Diez J, Panizo A, Hernańdez M, Vega F, Sola I, Fortun̄o MA, et al. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 1997; 30:1029-1034.
38. 1, and phorbol myristate acetate on cardiac fibroblasts. regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 1991; 69:483-490.
39. 1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90:455-461.
40. Timmermans PBMWM, Wong PC, Chiu AT, Smith RD. The preclinical basis of the therapeutic evaluation of losartan. J Hypertens 1995; 13 (suppl 1):S1-S13.
41. Siegl PKS, Kivlighn SD, Broten TP. Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertension. J Hypertens 1995; 13 (suppl 1);Sl5-S21.
42. 1 receptor blockade on cardiac remodeling after myocardial infarction. Cardiovasc Res 1997; 35:223-232.
43. Miyahara M, Njieha FK, Prockop DJ. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases. J Biol Chem 1982; 257:8442-8448.
44. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts. response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26:809-820.
45. Junqueira LCU, Bignolas G, Brentani RR. A simple and sensitive method for the quantitative estimation of collagen. Anal Biochem 1979; 94:96-99.
46. Mukherjee D, Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res 1990; 67:1474-1480.